IP Verse

Sclerostin Epitopes - EP2345668

The patent EP2345668 was granted to Amgen on Sep 22, 2021. The application was originally filed on Apr 28, 2006 under application number EP10014360A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2345668

AMGEN
Application Number
EP10014360A
Filing Date
Apr 28, 2006
Status
Granted And Under Opposition
Aug 20, 2021
Grant Date
Sep 22, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEJun 21, 2022CARPMAELS & RANSFORDWITHDRAWN

Patent Citations (44) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2004009535
DESCRIPTIONUS2004146888
DESCRIPTIONUS2005106683
DESCRIPTIONUS2005238646
DESCRIPTIONUS2006016345
DESCRIPTIONUS32011
DESCRIPTIONUS4179337
DESCRIPTIONUS4301144
DESCRIPTIONUS4331647
DESCRIPTIONUS4411993
DESCRIPTIONUS4464456
DESCRIPTIONUS4496689
DESCRIPTIONUS4543439
DESCRIPTIONUS4640835
DESCRIPTIONUS4670417
DESCRIPTIONUS4791192
DESCRIPTIONUS4902614
DESCRIPTIONUS5145684
DESCRIPTIONUS5223409
DESCRIPTIONUS5399363
DESCRIPTIONUS5466468
DESCRIPTIONUS5543158
DESCRIPTIONUS5552157
DESCRIPTIONUS5565213
DESCRIPTIONUS5567434
DESCRIPTIONUS5627052
DESCRIPTIONUS5641515
DESCRIPTIONUS5698426
DESCRIPTIONUS5738868
DESCRIPTIONUS5795587
DESCRIPTIONUS5877397
DESCRIPTIONUS6133426
DESCRIPTIONUS6395511
DESCRIPTIONUS6703199
DESCRIPTIONUS6803453
DESCRIPTIONWO2006119062
DESCRIPTIONWO9202551
OPPOSITIONEP1636270
OPPOSITIONEP2325199
OPPOSITIONWO0032773
OPPOSITIONWO2005003158
OPPOSITIONWO2005014650
SEARCHWO2005003158
SEARCHWO2005014650

Non-Patent Literature (NPL) Citations (91) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ALTING-MEES ET AL., STRATEGIES IN MOLECULAR BIOLOGY, (1990), vol. 3, pages 1 - 9
DESCRIPTION- ANDREWS, S.M.; TITUS, J.A. ET AL., Current Protocols in Immunology, JOHN WILEY & SONS, (2003), pages 2.8.1 - 2.8.10,2
DESCRIPTION- ANGAL S ET AL., MOL IMMUNOL, (1993), vol. 30, no. 1, pages 105 - 108
DESCRIPTION- BABCOOK ET AL., PROC. NATL. ACAD. SCI. USA, (1996), vol. 93, pages 7843 - 48
DESCRIPTION- BALEMANS ET AL., HUM. MOL. GENET., (2001), vol. 10, pages 537 - 543
DESCRIPTION- BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426
DESCRIPTION- BOERNER, J. LINMUNOL, (1991), vol. 147, pages 86 - 95
DESCRIPTION- BOWIE ET AL., SCIENCE, (1991), vol. 253, pages 164 - 170
DESCRIPTION- BRENNER ET AL., CURR. OP. STRUCT BIOL, (1997), vol. 7, no. 3, pages 369 - 376
DESCRIPTION- BRUGGEMANN ET AL., CURR. OPIN. BIOTECHNOL., (1997), vol. 8, pages 455 - 58
DESCRIPTION- BRUNKOW ET AL., AM. J. HUM. GENET., (2001), vol. 68, pages 577 - 589
DESCRIPTION- BURTON ET AL., ADV. IMMUNOL., (1994), vol. 57, pages 191 - 280
DESCRIPTION- BYRNE, F. R ET AL., GUT, (2005), vol. 54, pages 78 - 86
DESCRIPTION- CALVARIA., J. CELL BIOL., vol. 96, pages 191 - 198
DESCRIPTION- CHANDRAN ET AL., INDIAN J. EXP. BIOL., (1997), vol. 35, no. 8, pages 801 - 09
DESCRIPTION- CHOU ET AL., ADV. ENZYMOL. RELAT. AREAS MOL. BIOL., (1978), vol. 47, pages 45 - 148
DESCRIPTION- CHOU ET AL., ANN. REV. BIOCHEM., vol. 47, pages 251 - 276
DESCRIPTION- CHOU ET AL., BIOCHEMISTRY, (1974), vol. 113, no. 2, pages 211 - 222
DESCRIPTION- CHOU ET AL., BIOCHEMISTRY, (1974), vol. 13, no. 2, pages 222 - 245
DESCRIPTION- CHOU ET AL., BIOPHYS. J., (1979), vol. 26, pages 367 - 384
DESCRIPTION- CLARK, M., IMMUNOLOGY TODAY, (2000), vol. 21, no. 8, pages 397 - 402
DESCRIPTION- COMIER, CURR. OPIN. IN RHEU., (1995), vol. 7, page 243
DESCRIPTION- COUVREUR ET AL., CRIT. REV. THER. DRUG CARRIER SYST., (1988), vol. 5, no. 1, pages 1 - 20
DESCRIPTION- CRAMERI ET AL., NATURE, (1998), vol. 391, pages 288 - 291
DESCRIPTION- Current Protocols in Immunology, JOHN WILEY & SONS, (1991), vol. 1, pages 2.5.1 - 2.6.7
DESCRIPTION- DALL'ACQUA WF ET AL., METHODS, (2005), vol. 36, no. 1, pages 43 - 60
DESCRIPTION- EDELMAN ET AL., Methods in Enzymology, ACADEMIC PRESS, (1967), vol. 1, page 422
DESCRIPTION- FROST, H.M.; JEE, W.S.S.; BONE; MINERAL, QN THE RAT MODEL OF HUMAN OSTEOPENIAS AND OSTEOPOROSIS, (1992), vol. 18, pages 227 - 236
DESCRIPTION- GLASKY ET AL., HYBRIDOMA, (1989), vol. 8, pages 377 - 89
DESCRIPTION- GREEN ET AL., NATURE GENET., (1994), vol. 7, page 13
DESCRIPTION- GRIBSKOV ET AL., METH. ENZYM., (1990), vol. 183, pages 146 - 159
DESCRIPTION- GRIBSKOV ET AL., PROC. NAT. ACAD. SCI., (1987), vol. 84, no. 13, pages 4355 - 4358
DESCRIPTION- GUINNESS-HEY, METAB. BONE DIS. RELAT. RES., (1984), vol. 5, pages 177 - 181
DESCRIPTION- HARRIS, RJ., JOURNAL OF CHROMATOGRAPHY, (1995), vol. 705, pages 129 - 134
DESCRIPTION- HOLLINGER; HUDSON, NATURE BIOTECHNOLOGY, (2005), vol. 23, no. 9, pages 1126 - 1136
DESCRIPTION- HOLM ET AL., NUCL. ACID. RES., (1999), vol. 27, no. 1, pages 244 - 247
DESCRIPTION- HOOGENBOOM ET AL., J. MOLEC. BIOL., (1992), vol. 227, pages 381 - 388
DESCRIPTION- HUSE ET AL., SCIENCE, (1989), vol. 246, pages 1275 - 81
DESCRIPTION- HWANG W. ET AL., METHODS., (2005), vol. 36, no. 1, pages 35 - 42
DESCRIPTION- JAKOBOVITS ET AL., ANN. N. Y ACAD SCI., (1995), vol. 764, pages 525 - 35
DESCRIPTION- JEE, W.S.S.; YAO, W., "Overview: animal models of osteopenia and osteoporosis", J MUSCULOSKEL. NEURON. INTERACT., (2001), vol. 1, pages 193 - 207
DESCRIPTION- JONES, D., CURR. OPIN. STRUCT BIOL., (1997), vol. 7, no. 3, pages 377 - 87
DESCRIPTION- KALU, DN.; BONE; MINERAL, THE OVARIECTOMIZED RAT MODEL OFPOSIMENOPAUSAL BONE LOSS, (1991), vol. 15, pages 175 - 192
DESCRIPTION- KANG ET AL., PROC. NATL. ACAD. SCI. USA, (1991), vol. 88, pages 4363 - 66
DESCRIPTION- KHOSLA; RIGGS, MAYO, CLIN. PROC., (1995), vol. 70, page 978982
DESCRIPTION- KOHLER ET AL., NATURE, (1975), vol. 256, page 495
DESCRIPTION- KRAMER ET AL., NUCLEIC ACIDS RES., (1984), vol. 12, page 9441
DESCRIPTION- KUNKEL ET AL., METHODS IN ENZYMOL., (1987), vol. 154, pages 367 - 82
DESCRIPTION- KUNKEL, PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, pages 488 - 92
DESCRIPTION- LARRICK ET AL., A COMPANION TO METHODS IN ENZYMOLOGY, (1991), vol. 2, page 106
DESCRIPTION- LASIC, TRENDS BIOTECHNOL., (1998), vol. 16, no. 7, pages 307 - 21
DESCRIPTION- LONBERG, NATURE, (1994), vol. 368, page 856
DESCRIPTION- LOW ET AL., J. MOL. BIOL., (1996), vol. 250, pages 350 - 368
DESCRIPTION- MARGALIT, CRIT. REV. 7HER. DRUG CARRIER SYST., (1995), vol. 12, no. 2-3, pages 233 - 61
DESCRIPTION- MARKS ET AL., BIO/TECHNOLOGY, (1992), vol. 10, pages 779 - 783
DESCRIPTION- "Monoclonal Antibodies: Principles and Applications, Birch", WARD ET AL., Genetic Manipulation and Expression of Antibodies, WILEY-LISS, INC., (1995), page 137
DESCRIPTION- "Monoclonal Antibodies: Production, Engineering and Clinical Application", COURTENAY-LUCK ET AL., Genetic Manipulation of Monoclonal Antibodies, CAMBRIDGE UNIVERSITY PRESS, (1995), page 166
DESCRIPTION- MOULT J., CURR. OP. IN BIOTECH., (1996), vol. 7, no. 4, pages 422 - 427
DESCRIPTION- NISONOFF ET AL., ARCH. BIOCHEM. BIOPHYS., (1960), vol. 89, page 230
DESCRIPTION- NYGREN; UHLEN, URRENT OPINION IN STRUCTURAL BIOLOGY, (1997), vol. 7, pages 463 - 469
DESCRIPTION- PATTEN ET AL., CURR. OPIN. BIOTECHNOL., (1997), vol. 8, pages 724 - 733
DESCRIPTION- PLUCKTHUN ET AL., METHODS ENZYMOL., (1989), vol. 178, pages 497 - 515
DESCRIPTION- PORTER, BIOCHEM. J., (1959), vol. 73, page 119
DESCRIPTION- "Production of monoclonal antibodies against proteins expressed in E. coli", PICKSLEY ET AL., DNA Cloning 2: Expression Systems, OXFORD UNIVERSITY PRESS, (1995), page 93
DESCRIPTION- "Purification of Immunoglobulin G (IgG)", BAINES ET AL., Methods in Molecular Biology, THE HUMANA PRESS, INC., (1992), vol. 10, pages 79 - 104
DESCRIPTION- QUINTANAR-GUERRERO ET AL., DRUG DEV. IND PHARM, (1998), vol. 24, no. 12, pages 1113 - 28
DESCRIPTION- Remington's Pharmaceutical Sciences, pages 1035 - 1038,157
DESCRIPTION- RIGGS, WEST, J. MED., (1991), vol. 154, pages 63 - 77
DESCRIPTION- SANGER ET AL., PNAS, (1977), vol. 74, page 5463
DESCRIPTION- SASTRY ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 5728 - 32
DESCRIPTION- SCATCHARD ET AL., ANN. N.Y. ACAD. SCI., (1949), vol. 51, pages 660 - 672
DESCRIPTION- SCHLEBUSCH ET AL., HYBRIDOMA, (1997), vol. 16, pages 47 - 52
DESCRIPTION- SIPPL ET AL., STRUCTURE, (1996), vol. 4, no. 1, pages 15 - 19
DESCRIPTION- SMITH E; REDMAN R; LOGG C; COETZEE G; KASAHARA N; FRENKEL B., "Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle", JBIO1 CHEM, (2000), vol. 275, pages 19992 - 20001
DESCRIPTION- SMITH E; REDMAN R; LOGG C; COETZEE G; KASAHARA N; FRENKEL B, "Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle", J. BIOL. CHEM., (2000), vol. 275, pages 19992 - 20001
DESCRIPTION- TAKAKURA, NIPPON RINSHO, (1998), vol. 56, no. 3, pages 691 - 95
DESCRIPTION- TAYLOR, INT. IMMUN., (1994), vol. 6, page 579
DESCRIPTION- THOMPSON ET AL., J. MOL. BIOL., (1996), vol. 256, pages 7 - 88
DESCRIPTION- THORNTON ET AL., NATURE, (1991), vol. 354, page 105
DESCRIPTION- VAUGHAN ET AL., NATURE BIOTECHNOLOGY, (1998), vol. 16, pages 535 - 539
DESCRIPTION- WINTER ET AL., ANNU. REV: IMMUNOL., (1994), vol. 12, pages 433 - 55
DESCRIPTION- WOLFF ET AL., CANCER RES., (1993), vol. 53, pages 2560 - 65
DESCRIPTION- YANG ET AL., J. MOL. BIOL., (1995), vol. 254, pages 392 - 403
DESCRIPTION- ZAMBAUX ET AL., J. CONTROLLED RELEASE, (1998), vol. 50, no. 1-3, pages 31 - 40
DESCRIPTION- ZHANG, W. ET AL., MOLECULAR IMMUNOLOGY, (2005), vol. 42, no. 12, pages 1445 - 1451
DESCRIPTION- ZUR MUHLEN ET AL., EUR. J. PHARM. BIOPHARM., (1998), vol. 45, no. 2, pages 149 - 55
DESCRIPTION- SUDO H; KODAMA H-A; AMAGAI Y; YAMAMOTO S; KASAI S, "In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria", J CELL BIOL, (1983), vol. 96, doi:doi:10.1083/jcb.96.1.191, pages 191 - 198, XP002000687
DESCRIPTION- SUDO H; KODAMA H-A; AMAGAI Y; YAMAMOTO S; KASAI S, "In vitro differentiation and calcification in a new clonal osteogenic cell line derivedfrom newborn mouse calvaria", J. CELL BIOL., (1983), vol. 96, doi:doi:10.1083/jcb.96.1.191, pages 191 - 198, XP002000687
OPPOSITION- Van Bezooijen Rutger L., Roelen Bernard A.J., Visser Annemieke, Van Der Wee-Pals Lianne, De Wilt Edwin, Karperien Marcel, Hamersma Herman, Papapoulos Socrates E., Ten Dijke Peter, Löwik Clemens W.G.M., J. Exp. Med., (20040000), vol. 199, no. 6, pages 805 - 814, XP002391779
OPPOSITION- WARMINGTON K; MORONY S; SAROSI I; GONG J; STEPHENS P; WINKLER D G; SUTHERLAND M K; LATHAM J A; KIRBY H; MOORE A; ROBINSON M; KOSTENUIK P J; SIMONET S; LACEY D L; PASZTY C, "SCIEROSTIN ANTAGONISM IN ADULT RODENTS, VIA MONOCLONAL ANTIBODY MEDIATED BLOCKADE, INCREASES BONE MINERAL DENSITY AND IMPLICATES SCLEROSTIN AS A KEY REGULATOR OF BONE MASS DURING ADULTHOOD", 1217 at American Society for Bone and Mineral Research annual meeting, Seattle, (20041000), vol. 19, page 1, XP009072609
SEARCH- AVSIAN-KRETCHMER ORNA ET AL, "Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists.", MOLECULAR ENDOCRINOLOGY, (200401), vol. 18, no. 1, ISSN 0888-8809, pages 1 - 12, XP002400896 [A] 1-17 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents